TSPO and neoplasm: First preclinical and clinical studies using high affinity TSPO PET ligands, e.g., [18F]GE180 or [18F]DPA-714, have shown that tumor volumes on TSPO and amino acid PET or MRI images differ between modalities [18,19,20,21].